Short answer · Medically reviewed summary · Last updated: 2026-05-08
Leber Hereditary Optic Neuropathy (LHON) is primarily managed through the use of idebenone, a synthetic analog of coenzyme Q10, which aims to improve mitochondrial function and protect retinal ganglion cells. Because there is currently no cure, treatment focuses on early intervention to preserve remaining vision and utilizing assistive technologies to support daily living for those affected by Leber Hereditary Optic Neuropathy. What are the current medical treatments for Leber Hereditary Optic Neuropathy? The primary pharmacological treatment for Leber Hereditary Optic Neuropathy is idebenone (Raxone).
1 people with Leber Hereditary Optic Neuropathy have shared their first-person experience on this question at DiseaseMaps.
What are the best treatments for Leber Hereditary Optic Neuropathy?
Treatments for Leber Hereditary Optic Neuropathy: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
Leber Hereditary Optic Neuropathy (LHON) is primarily managed through the use of idebenone, a synthetic analog of coenzyme Q10, which aims to improve mitochondrial function and protect retinal ganglion cells. Because there is currently no cure, treatment focuses on early intervention to preserve remaining vision and utilizing assistive technologies to support daily living for those affected by Leber Hereditary Optic Neuropathy.
What are the current medical treatments for Leber Hereditary Optic Neuropathy?
The primary pharmacological treatment for Leber Hereditary Optic Neuropathy is idebenone (Raxone). Clinical guidelines often recommend its use as soon as possible following the diagnosis of Leber Hereditary Optic Neuropathy to potentially stabilize or improve visual acuity. While idebenone is approved in the European Union, its availability and approval status vary globally. It is essential to consult with a neuro-ophthalmologist to determine if this therapy is appropriate for a patient's specific genetic mutation and stage of vision loss.
What non-pharmacological support is available?
Since Leber Hereditary Optic Neuropathy often results in significant visual impairment, non-pharmacological support is vital. This includes low-vision rehabilitation, which helps patients adapt to central vision loss. Common strategies for managing Leber Hereditary Optic Neuropathy include:
- Occupational Therapy: Training for navigation and daily living skills.
- Assistive Technology: Utilizing screen readers, high-contrast displays, and magnification software.
- Psychological Counseling: Managing the emotional impact of rapid vision loss, a common experience among the 57 community members on DiseaseMaps.org.
Are there emerging treatments or clinical trials?
Research into Leber Hereditary Optic Neuropathy is rapidly evolving, particularly in the field of gene therapy. Several clinical trials are investigating the use of viral vectors to deliver functional copies of mitochondrial genes (such as ND4) directly into the eye. These studies aim to restore mitochondrial function in patients with Leber Hereditary Optic Neuropathy, offering hope for future breakthroughs in regenerative medicine.
Which specialists should be on the care team?
Effective management of Leber Hereditary Optic Neuropathy requires a multidisciplinary approach. Your care team should ideally include:
- Neuro-ophthalmologist: To oversee vision monitoring and pharmacological treatment.
- Clinical Geneticist: To provide family counseling and identify specific mitochondrial DNA mutations.
- Low Vision Specialist: To provide tools for visual adaptation.
- Psychotherapist: To support mental health during the adjustment process.
Next steps
- Consult a neuro-ophthalmologist to discuss the latest clinical trial eligibility.
- Connect with the 57 members of the DiseaseMaps.org community to share experiences and coping strategies.
- Schedule a comprehensive genetic consultation to understand the inheritance patterns of your specific mutation.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your physician for personalized treatment protocols.
References
- NIH Genetic and Rare Diseases Information Center (GARD) - Leber Hereditary Optic Neuropathy
- Orphanet - Rare Disease Database (ORPHA: 263)
- OMIM (Online Mendelian Inheritance in Man) - Mitochondrial DNA mutations associated with LHON
- The Leber Hereditary Optic Neuropathy Society (LHONS)
Some studies show that the medicine idebenone with vitamin B and vitamin C can be effective, especially for people who have the onset of the disease. Another medicine called EPI-743 has been used in a small study with good results. It is recommended not to drink alcohol and not smoke, and avoid contact with other factors such as industrial toxins.
Source: https://rarediseases.info.nih.gov/espanol/13049/neuropatia-optica-hereditaria-de-leber#diseaseTratamientoSection
Posted May 20, 2017 by Enrique Guzmán 1370
